期刊文献+

环孢菌素A-纳米乳输液剂的制备及鉴定 被引量:2

Development and characterization of cyclosporine A nanoparticles emulsion
下载PDF
导出
摘要 目的制备鉴定负载环孢菌素A(Cyclosporine A,CsA)的纳米乳(Cyclosporine A-nanopaticals e-mulsion,CsA-NP)并评估CsA-NP对体外干细胞增殖和分化的影响。方法采用乳化法制备油水(o/w)型CsA-NP。以蛋黄磷脂(Lipoid E 80)、泊洛沙姆188为水相,中链油(Lipoid MCT)为油相,采用高压均质法制备而成。高效液相色谱法(HPLC)评估产品的载药率,乳径的粒径经激光粒度分析仪测定。CsA-NP对干细胞增殖和分化影响采用细胞直接计数和MTT检测。结果本研究制备的CsA-NP工艺稳定性好,粒径均匀,50%的乳滴微粒直径在162 nm以内。CsA-NP浓度在(0.01~1 mg/mL)之间1~3 d对细胞增殖有明显促进作用(P<0.01);其中又以0.5 mg/mL的CsA-NP浓度组为最佳。结论CsA-NP是一种稳定性良好的静脉注射用纳米乳。 Objective To make and evaluate the ability of cyclosporine incorporated into nanoparticles emulsion(CsA-NP),as well as the effects of CsA-NP on stem cells proliferation in vitro.Methods An oil-in-water(o/w)emulsification-diffusion method was used to prepare cyclosporin A-loaded nanoparticles(CsA-NP)intravenous emulsion.CsA-NP emulsion was prepared by the high pressure homogenization method,using Lipoid E 80 and poloxamer 188 as emulsifiers,Lipoid MCT as the oil phase.The products were evaluated by measuring drug loading with high performance liquid chromatography(HPLC),particle sizing by dynamic light scattering(DLS).The proliferation and differentiation of CsA-NP on stem cells were measured by direct cell counting and MTT assay,respectively.Results The prepared with the optimized formulation was stable with uniform particle size distribution and the dimension of 50% emulsion droplets was less than 162 nm.The proliferation of stem cells were stimulated by 0.01~1 mg/mL CsA-NP for 1~3 d(P0.01);and the best proliferative effect was observed at concentration of 0.5 mg/mL.Conclusion Intravenous CsA-NP emulsion is stable as a new type of drug delivery system.
出处 《实用药物与临床》 CAS 2013年第7期600-603,共4页 Practical Pharmacy and Clinical Remedies
基金 "863"课题(2006AA02A105)
关键词 环孢菌素A 纳米 干细胞 增殖 Cyclosporin A Nanoparticles Stem cells Proliferation
  • 相关文献

参考文献10

  • 1Cour M, Loufouat J, Paillard M, et al. Inhibition of mitochon- drial permeability transition to prevent the post-cardiac arrest syndrome: a pre-clinical study [ J ]. Eue Heart J,2011,32 ( 2 ) : 226-235.
  • 2Kockx M, Jessup W, Kritharides L. Cyclosporin A and athero- sclerosis-Cellular pathways in atherogenesis[ J]. Pharmacology & Therapeutics ,2010,128 ( 1 ) : 106-118.
  • 3杜美蓉,李大金.环孢素A的药效学研究[J].中国药学杂志,2005,40(1):1-3. 被引量:7
  • 4Takebe G, Takagi T, Suzuki M, et al. Preparation of polymeric nanoparticles of cyclosporin A using infrared pulsed laser[ J]. International Journal of Pharmaceutics, 2011,414 ( 1-2 ) : 244- 250.
  • 5Zhang Y, Li X, Zhou Y, et al. Preparation and evaluation of poly( ethylene glycol) - poly(lactide) micelles as nanocarriers for oral delivery of cyclosporine a [ J ]. Nanoscale Res Lett, 2010,5(6) :917-925.
  • 6Monaco E, Bionaz M, Rodriguez-Zas S, et al. Transcriptomics comparison between porcine adipose and bone marrow mesen- chymal stem cells during in vitro osteogenic and adipogenic differentiation [ J ]. PLoS One,2012,7 ( 3 ) : e32481.
  • 7Gupta V, Davis M, Hope-Weeks L J, et al. PLGA microparti- cles encapsulating prostaglandin El-hydroxypropyl-13-cyclo- dextrin ( PGE1 -HP[3CD) complex for the treatment of pulmona- ry arterial hypertension (PAH) [ J ]. Pharm Res, 2011,28 ( 7 ) : 1733-1749.
  • 8Chu-fan L, Xing W, Xun H, et al. Protective effect of lipid mi- crospheres on myocardial injury following elective percutane- ous coronary intervention in patients with angina pectoris : a pi- lot study[ J]. J Cardiovasc Med(Hagerstown) ,2011,12 ( 11 ) : 790-794.
  • 9Yan P, Nagasawa A, Uosaki H, et al. Cyclosporin-A potently induces highly cardiogenic progenitors from embryonic stem cells [ J ]. Biochem Biophys Res Commun ,2009,379 ( 1 ) : 115- 120.
  • 10Masataka F, Peishi Y, Tomomi O, et al. Induction and en- hancement of cardiac cell differentiation from mouse and hu- man induced pluripotent stem cells with cyclosporin-A [ J ]. PLoS One,2011,2(22) :1-10.

二级参考文献23

  • 1Zhang BW, Zmmer G, Chen I, et al. T cell responses in calcineurin A alpha-deficient mice[J]. J Exp Med, 1996,183:413.
  • 2Hojo M, Morimoto T, Maluccio M, et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism [ J ] . Nature, 1999,397: 530.
  • 3Hughes PE, Alexi T, Walton M, et al. Activity and ingury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system[ J ]. Prog Neurobiol , 1999,57:421.
  • 4Bueno OF, Rooij EV, Molkentin JD, et al. Calcineurin and hypertrophic aeart disease: novel insights and remainding questions [ J ].Cardiovasc Res ,2002,53: 806.
  • 5Kreideweiss S, Ahlers C, Nordheim A, et al. Ca2+ -induced p38/SAPKsignalling inhibited by the immunosuppressant cyclosporin A in human peripheral blood mononuclear cells[ J]. Eur J Biochem, 1999,265:1075.
  • 6Costantini P, Jacotot E, Decaudin D, et al. Motochondrion as a novel target of anticancer chemotherapy [ J ] . J Natl Cancer Inst , 2000,92(13): 1042.
  • 7Brenner C,Cadiou H, Vieira HL, etal. Bcl-2 and Bax regulate the channel activity of the mitochondria adenine nudeotide translocater[J]. Oncogene ,2000,19:329.
  • 8Halestrap AP, Woodfield KY, Connern CP, et al. Oxidative stress,thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase [ J ]. J Biol Chem, 1997,272: 3346.
  • 9Scorrano L, Ashiya M, Buttle K, et al. A distinct pathway remodels mitochontrial cristae and mobilize cytochrome c during apoptosis[J].Dev Cell ,2002,2(1 ) :55.
  • 10Kim JS, Qian T, Lemasters JJ. Mitochondrial permeability transition in the switch from necrotic to apoptotic cell death in ischemic rat hepatocytes [ J ]. Gastroenterology, 2003,124(2) :494.

共引文献6

同被引文献19

  • 1韩涛,李富荣,周汉新.阿霉素纳米微球靶向药物制剂的研究进展[J].中国药物与临床,2004,4(10):737-740. 被引量:5
  • 2陈英杰,许向阳,周建平.乳酸-羟基乙酸共聚物微球的研究进展[J].中国药科大学学报,2007,38(2):186-189. 被引量:11
  • 3Gabler F, Frauenschuh S, Ringe J, et al. Emulsion-based synthesis of PLGA-microspheres for the in vitro expansion of porcine chondrocytes [ J ]. Biomol Eng, 2007,24 ( 5 ) : 515-520.
  • 4Tahara K, Kato Y, Yamamoto H, et al. Intracellular drug delivery using polysorbate 80-modifiedpoly (D, L-lactide-co- glycolide) nanospheres to glioblastoma cells [J]. J Microencapsul, 2011,28(1) :29-36.
  • 5Zou L, Song X, Yi T, et al. Administration of PLGA nanoparticles carrying shRNA against focal adhesion kinase and CD44 results in enhanced antitumor effects against ovarian cancer [J]. Cancer Gene Ther, 2013,20(4) : 242-250.
  • 6ChavanpatilM D, Patil Y, Panyam J. Susceptibility of nanoparticle-encapsu lated paclitaxel to P-glycoprotein- mediated drug efflux [Jl. Int J Ph arm, 2006,320(1-2) : 150-156.
  • 7Barraud L, Merle P, Soma E, et al.Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma ceils in vitro and in vivo [J]. J Hepatol, 2005 , 42(5) : 736-743.
  • 8Kim JH,Jang SW,Han SD,et al.Development of a novel ophthalmic ciclosporin A-loaded nanosuspension using topdown media milling methods[J].Die Pharmazie,2011,66(7):491-495.
  • 9Hideyuki S,Yohei K,Kayo Y,et al.Comparative studies on physicochemical stability of cyclosporine A-loaded amorphous solid dispersions[J].Int J Pharmac,2012,426(1):302-306.
  • 10梁晓飞,王汉杰,罗浩,田惠,支敏,王永兰,常津.生物降解多功能缓释微球的制备与表征[J].化学学报,2008,66(19):2178-2183. 被引量:11

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部